BOULDER, Colo., Jan. 12, 2026 /PRNewswire/ -- Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today ...
Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation associated with Alzheimer’s disease. BOULDER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results